SPRED1 anticorps (N-Term)

N° du produit ABIN544062

Détail du produit anti-SPRED1 anticorps

Antigène: SPRED1 (Sprouty-Related, EVH1 Domain Containing 1 (SPRED1))

Épitope: N-Term

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp SPRED1 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Fonction: Rabbit polyclonal antibody raised against synthetic peptide of SPRED1.

Réactivité croisée: Humain

Immunogène: A synthetic peptide (conjugated with KLH) corresponding to N-terminus of human SPRED1.

Information d'application

Indications d'application: Western Blot (1:1000)
Immunohistochemistry (1:10-50)
The optimal working dilution should be determined by the end user.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: In PBS (0.09 % sodium azide)

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.

Références pour anticorps anti-SPRED1 (ABIN544062)

Szafranski, Schindler, Taudien, Hiller, Huse, Jahn, Schreiber, Backofen, Platzer: "Violating the splicing rules: TG dinucleotides function as alternative 3' splice sites in U2-dependent introns." dans: Genome biology, Vol. 8, Issue 8, pp. R154, (2008) (PubMed).

Brems, Chmara, Sahbatou, Denayer, Taniguchi, Kato, Somers, Messiaen, De Schepper, Fryns, Cools, Marynen, Thomas, Yoshimura, Legius: "Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype." dans: Nature genetics, Vol. 39, Issue 9, pp. 1120-6, (2007) (PubMed).

Yoshida, Hisamoto, Akiba, Koga, Nakamura, Tokunaga, Hanada, Kumemura, Maeyama, Harada, Ogata, Yano, Kojiro, Ueno, Yoshimura, Sata: "Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors." dans: Oncogene, Vol. 25, Issue 45, pp. 6056-66, (2006) (PubMed).

Détails sur SPRED1

Antigène: SPRED1 (Sprouty-Related, EVH1 Domain Containing 1 (SPRED1))

Autre désignation: SPRED1 (SPRED1 Produits)

Synonymes: anticorps fb14c08, anticorps fj51c03, anticorps zgc:85707, anticorps wu:fb14c08, anticorps wu:fj51c03, anticorps Xspred1, anticorps Xtspred1, anticorps 5730461F13Rik, anticorps AL024345, anticorps AW047647, anticorps NFLS, anticorps hSpred1, anticorps spred-1, anticorps sprouty-related, EVH1 domain containing 1, anticorps sprouty related EVH1 domain containing 1, anticorps sprouty related, EVH1 domain containing 1, anticorps sprouty related, EVH1 domain containing 1 L homeolog, anticorps SPRED1, anticorps sprouty protein with EVH-1 domain 1, related sequence, anticorps spred1, anticorps SPRED1, anticorps spred1.L, anticorps Bm1_51610, anticorps Spred1

ID gène: 161742

Pathways: Positive Regulation of Response to DNA Damage Stimulus